You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Copy file name to clipboardExpand all lines: principles/fp-009-users.md
+29-29Lines changed: 29 additions & 29 deletions
Display the source diff
Display the rich diff
Original file line number
Diff line number
Diff line change
@@ -20,7 +20,7 @@ scientific area and does so in a usable and sustainable fashion.
20
20
It is important to be able to illustrate usage outside of the immediate circle of ontology developers and stakeholders. Demonstrations of usage MUST be publicly available. Preferred indicators of usage are those that directly demonstrate such, including:
21
21
22
22
- Use of the target ontology's term IRIs in an external ontology. Indicators of this type MUST include one or more IRIs for a term _within the external ontology_ that uses a term from the target ontology.
23
-
23
+
24
24
- Documentation of requests from multiple users. Indicators of this type MUST link to specific requests in the issue tracker, OR link to an issue tracker search (for example, showing new term requests), OR link to an email thread or other mechanism _if publicly viewable_.
25
25
26
26
- Publications showing the ontology being used in research by external users. Indicators of this type MUST provide citation details for the publications (link to PubMed or full text) and MUST include a sentence demonstrating the use (preferably taken from the title, abstract, or full text of the cited reference). Note that if citing full text that is behind a paywall, it may be necessary to provide a PDF for the paper.
@@ -42,7 +42,7 @@ Other indicators are currently possible as well:
42
42
within some community (mere mention of the existence is not enough
43
43
to warrant inclusion).
44
44
45
-
Note that the ontology can still be listed on the OBO Foundry website while publicising your resource in appropriate channels and searching for users with needs you can meet.
45
+
Note that the ontology can still be listed on the OBO Foundry website while publicising your resource in appropriate channels and searching for users with needs you can meet.
46
46
47
47
## Implementation
48
48
@@ -51,58 +51,58 @@ use within your ontology [metadata file](https://github.com/OBOFoundry/OBOFoundr
51
51
52
52
```yaml
53
53
usages:
54
-
- user: http://www.informatics.jax.org/disease (link to group)
55
-
description: MGI disease model annotations use DO (description of group)
54
+
- description: MGI disease model annotations use DO (description of group)
56
55
examples:
57
-
- url: http://www.informatics.jax.org/disease/DOID:4123 (link to specific example)
58
-
description: Human genes and mouse homology associated with nail diseases (description of specific example)
56
+
- description: Human genes and mouse homology associated with nail diseases (description of specific example)
57
+
url: "http://www.informatics.jax.org/disease/DOID:4123"# link to specific example)
58
+
user: "http://www.informatics.jax.org/disease"# link to group
59
59
```
60
60
61
-
You may have multiple examples for each user, and mulitple users under the `usages` tag.
61
+
You may have multiple examples for each user, and multiple users under the `usages` tag.
62
62
63
63
## Examples
64
64
65
65
Use of PSI-MOD term IRI (in the form of a CURIE) in the PR ontology:
Publication showing the Disease Ontology being used in research by external users
82
82
```yaml
83
-
- user: https://pubmed.ncbi.nlm.nih.gov/36860337/
84
-
description: Machine learning-based prediction of candidate gene biomarkers correlated with immune infiltration in patients with idiopathic pulmonary fibrosis
83
+
- description: Machine learning-based prediction of candidate gene biomarkers correlated with immune infiltration in patients with idiopathic pulmonary fibrosis
85
84
examples:
86
-
- url: https://pubmed.ncbi.nlm.nih.gov/36860337/
87
-
description: In abstract, "Functional annotation, pathway enrichment, Disease Ontology and gene set enrichment analyses revealed..."
85
+
- description: 'In abstract, "Functional annotation, pathway enrichment, Disease Ontology and gene set enrichment analyses revealed..."'
0 commit comments